A Refreshed AI & ML Focus Day
The interest in AI & ML applications in GPCR-targeted drug discovery is accelerating, but many uncertainties remain. As the field pushes toward deeper computational integration, key questions continue to shape the path forward, including:
- Can AI accurately predict GPCR structure, dynamics, and conformational flexibility?
- To what extent can AI model ligand-GPCR interactions across modalities?
- Can AI enhance target deconvolution and reveal new druggable GPCRs?
- How do we overcome data scarcity, bias, and low-quality datasets?
- Can AI design GPCR-biased ligands or predict signaling outcomes?
- What is required to build validated, interpretable, regulatory-ready models?
- How reliably can AI integrate structural, pharmacological, and dynamic data?
Our speakers will address these challenges throughout the day, with a panel discussion providing an opportunity to ask your own questions on the future of AI in GPCR drug discovery.
Real-World Translation Stories
In 2026, we're shining a spotlight on the translational breakthroughs moving GPCR-targeted therapeutics from discovery toward clinical reality. Learn how experts are engineering long-acting molecules, refining polypharmacology, leveraging systems biology, and deploying biomarker-driven strategies to de-risk and accelerate clinical development.
Explore The Full Event Guide
- Explore the complete 2027 agenda, featuring a dedicated focus day deep dive into emerging discovery technologies alongside two days of cutting-edge GPCR science.
- Preview exclusive sessions from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, and University of Miami.
- Discover how the industry is tackling GPCR discovery's biggest challenges, from target validation and signaling biology to AI accountability and biased agonism.
- See who you'll be networking with, including scientific decision-makers from leading pharma, biotech, and academic organizations.
- Identify the sessions, speakers, and networking opportunities most relevant to your programs before you attend.
Attending Companies Include
Explore the Agenda
Discover the latest advances in AI-enabled discovery, target validation, signaling biology, and emerging GPCR therapeutics across three days of scientific discussion.
Partner With Us
Showcase your expertise to a highly targeted audience of scientists and decision-makers actively seeking technologies, services, and partners to accelerate GPCR discovery.
Join the GPCR Community
Connect with leading pharma, biotech, and academic experts tackling the biggest challenges and opportunities shaping the future of GPCR drug discovery.